From: Albendazole-induced granulomatous hepatitis: a case report
Test | Baseline | At 2 months | At 6 months |
---|---|---|---|
Hemoglobin (g/dL) | 12.7 | 12.0 | 13.0 |
Hematocrit (%) | 44 | 43 | 42 |
Leukocytes (cells/mm3) | 8.400 | 7.650 | 7.990 |
Blood Platelets (platelets/mm3) | 140.000 | 250.000 | 180.000 |
Eosinophils (eos/mm3) | 260 | 300 | 310 |
Total bilirubin (mg/dL) | 13.75 | 1.1 | 1.2 |
Direct bilirubin (mg/dL) | 13.66 | 0.4 | 0.6 |
Aspartate aminotransferase (U/L) | 933 | 22 | 30 |
Alanine aminotransferase (U/L) | 1649 | 23 | 31 |
Alkaline phosphatase (U/L) | 145 | 75 | 62 |
Gamma glutamyl transpeptidase (U/L) | 28 | 17 | 15 |
Hepatitis A immunoglobulin M antibodies | Negative | Â | Â |
Hepatitis B surface antigen | Negative | Â | Â |
Hepatitis C antibody | Negative | Â | Â |
Human immunodeficiency virus antibodies | Negative | Â | Â |
Anti-smooth muscle antibodies | Positive 1:40 | Negative | Â |
Antinuclear antibodies | Negative | Negative | Â |
Immunoglobulin G (mg/dL) | 1.300 | 1.260 | Â |
Cytomegalovirus immunoglobulin M | Negative | Â | Â |
Epstein–Barr immunoglobulin M | Negative |  |  |
Herpes simplex immunoglobulin M | Negative | Â | Â |
Varicella immunoglobulin M | Negative | Â | Â |